Literature DB >> 15226429

Intra-S-phase checkpoint activation by direct CDK2 inhibition.

Yonghong Zhu1, Carmen Alvarez, Ronald Doll, Hirokazu Kurata, Xiao Min Schebye, David Parry, Emma Lees.   

Abstract

To ensure proper progression through a cell cycle, checkpoints have evolved to play a surveillance role in maintaining genomic integrity. In this study, we demonstrate that loss of CDK2 activity activates an intra-S-phase checkpoint. CDK2 inhibition triggers a p53-p21 response via ATM- and ATR-dependent p53 phosphorylation at serine 15. Phosphorylation of other ATM and ATR downstream substrates, such as H2AX, NBS1, CHK1, and CHK2 is also increased. We show that during S phase when CDK2 activity is inhibited, there is an unexpected loading of the minichromosome maintenance complex onto chromatin. In addition, there is an increased number of cells with more than 4N DNA content, detected in the absence of p53, suggesting that rereplication can occur as a result of CDK2 disruption. Our findings identify an important role for CDK2 in the maintenance of genomic stability, acting via an ATM- and ATR-dependent pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15226429      PMCID: PMC434231          DOI: 10.1128/MCB.24.14.6268-6277.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

1.  Surfing the p53 network.

Authors:  B Vogelstein; D Lane; A J Levine
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

Review 2.  The DNA damage response: putting checkpoints in perspective.

Authors:  B B Zhou; S J Elledge
Journal:  Nature       Date:  2000-11-23       Impact factor: 49.962

3.  Evidence for sequential action of cdc7 and cdk2 protein kinases during initiation of DNA replication in Xenopus egg extracts.

Authors:  J C Walter
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

4.  NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription.

Authors:  J Zhao; B K Kennedy; B D Lawrence; D A Barbie; A G Matera; J A Fletcher; E Harlow
Journal:  Genes Dev       Date:  2000-09-15       Impact factor: 11.361

Review 5.  Four-dimensional control of the cell cycle.

Authors:  J Pines
Journal:  Nat Cell Biol       Date:  1999-07       Impact factor: 28.824

6.  ATR is a caffeine-sensitive, DNA-activated protein kinase with a substrate specificity distinct from DNA-PK.

Authors:  C A Hall-Jackson; D A Cross; N Morrice; C Smythe
Journal:  Oncogene       Date:  1999-11-18       Impact factor: 9.867

7.  Inhibition of Mcm4,6,7 helicase activity by phosphorylation with cyclin A/Cdk2.

Authors:  Y Ishimi; Y Komamura-Kohno; Z You; A Omori; M Kitagawa
Journal:  J Biol Chem       Date:  2000-05-26       Impact factor: 5.157

8.  Caffeine abolishes the mammalian G(2)/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity.

Authors:  B B Zhou; P Chaturvedi; K Spring; S P Scott; R A Johanson; R Mishra; M R Mattern; J D Winkler; K K Khanna
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

9.  A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage.

Authors:  T T Paull; E P Rogakou; V Yamazaki; C U Kirchgessner; M Gellert; W M Bonner
Journal:  Curr Biol       Date:  2000 Jul 27-Aug 10       Impact factor: 10.834

10.  ERKs and p38 kinase phosphorylate p53 protein at serine 15 in response to UV radiation.

Authors:  Q B She; N Chen; Z Dong
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

View more
  19 in total

1.  A Cyclin-Dependent Kinase Inhibitor, Dinaciclib, Impairs Homologous Recombination and Sensitizes Multiple Myeloma Cells to PARP Inhibition.

Authors:  David A Alagpulinsa; Srinivas Ayyadevara; Shmuel Yaccoby; Robert J Shmookler Reis
Journal:  Mol Cancer Ther       Date:  2015-12-30       Impact factor: 6.261

2.  Loss of Emi1-dependent anaphase-promoting complex/cyclosome inhibition deregulates E2F target expression and elicits DNA damage-induced senescence.

Authors:  Emmy W Verschuren; Kenneth H Ban; Marilyn A Masek; Norman L Lehman; Peter K Jackson
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

3.  A high-throughput screen identifies miRNA inhibitors regulating lung cancer cell survival and response to paclitaxel.

Authors:  Liqin Du; Robert Borkowski; Zhenze Zhao; Xiuye Ma; Xiaojie Yu; Xian-Jin Xie; Alexander Pertsemlidis
Journal:  RNA Biol       Date:  2013-09-30       Impact factor: 4.652

4.  p53 and the PWWP domain containing effector proteins in chromatin damage repair.

Authors:  Jing Hu; Yanming Wang
Journal:  Cell Dev Biol       Date:  2013-05-10

5.  Plk1 phosphorylation of Orc2 promotes DNA replication under conditions of stress.

Authors:  Bing Song; X Shawn Liu; Korbin Davis; Xiaoqi Liu
Journal:  Mol Cell Biol       Date:  2011-09-26       Impact factor: 4.272

Review 6.  Cyclin-dependent kinases (cdks) and the DNA damage response: rationale for cdk inhibitor-chemotherapy combinations as an anticancer strategy for solid tumors.

Authors:  Neil Johnson; Geoffrey I Shapiro
Journal:  Expert Opin Ther Targets       Date:  2010-11       Impact factor: 6.902

7.  Disruption of mechanisms that prevent rereplication triggers a DNA damage response.

Authors:  Vincent Archambault; Amy E Ikui; Benjamin J Drapkin; Frederick R Cross
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

Review 8.  Cyclin-dependent kinase inhibitor therapy for hematologic malignancies.

Authors:  Prithviraj Bose; Gary L Simmons; Steven Grant
Journal:  Expert Opin Investig Drugs       Date:  2013-05-06       Impact factor: 6.206

9.  Cyclin-dependent kinases regulate apoptosis of intestinal epithelial cells.

Authors:  Sujoy Bhattacharya; Ramesh M Ray; Leonard R Johnson
Journal:  Apoptosis       Date:  2014-03       Impact factor: 4.677

10.  Hepatitis C virus NS5B protein delays s phase progression in human hepatocyte-derived cells by relocalizing cyclin-dependent kinase 2-interacting protein (CINP).

Authors:  Yaohui Wang; Yuchan Wang; Yan Xu; Wenyan Tong; Tingting Pan; Jianhua Li; Shuhui Sun; Junjie Shao; Huanping Ding; Tetsuya Toyoda; Zhenghong Yuan
Journal:  J Biol Chem       Date:  2011-05-31       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.